Jefferies Group LLC Logic Bio Therapeutics, Inc. Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$5.29 - $9.1 $179,584 - $308,926
-33,948 Closed
0 $0
Q3 2020

Nov 13, 2020
BUY
$5.41 - $9.45 $183,658 - $320,808
33,948 New
33,948 $308,000
Q4 2019

Feb 13, 2020
SELL
$7.01 - $11.01 $74,432 - $116,904
-10,618 Closed
0 $0
Q3 2019

Nov 13, 2019
BUY
$6.97 - $13.46 $74,007 - $142,918
10,618 New
10,618 $115,000

About LogicBio Therapeutics, Inc.

LOGC Quotes by TradingView
  • Ticker LOGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,962,700
  • Description
  • LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...
More about LOGC
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email